All comparisons
LLY vs NVO
Eli Lilly and Company vs Novo Nordisk A/S
Overview
LLYEli Lilly and Company
Score A+Price
$1,288.78
Fair Value
$1,526.58
Upside
+18.5%
Convex Score
10/10
NVONovo Nordisk A/S
Score BPrice
$38.29
Fair Value
$36.16
Upside
-5.6%
Convex Score
6/10
Valuation
LLY
Bear$1,159.90
Base$1,785.01
Bull$3,105.83
Fair Value$1,526.58
NVO
Bear$31.12
Base$37.84
Bull$43.91
Fair Value$36.16
Quality
LLY
Grade
A
Score
116/100
Classification
Growth
Rating
Score A+
NVO
Grade
A
Score
106/100
Classification
Compounder
Rating
Score B
Company Info
| LLY | NVO | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Growth | Compounder |
Verdict
LLY has better risk/reward
LLY: Higher upside potentialLLY: Higher Convex ScoreLLY: Better quality grade